Porphyria Cutanea Tarda

DBCOND0000759Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesDigestive System Diseases

Porphyria Cutanea Tarda is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
cutanea porphyria tarda · PCT
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0026011ICD-10E80.1SNOMED CT61860000MedDRA10011665UMLSC0162566

What you can answer from here — as of October 24, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Porphyria Cutanea Tarda share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In